Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Clears SalutarisMD's SMD-Sr90-DA Radionuclide Brachytherapy Source - Medical Product Outsourcing
OEM News

FDA Clears SalutarisMD’s SMD-Sr90-DA Radionuclide Brachytherapy Source

The minimally invasive procedure can be performed in an outpatient setting in approximately 15 minutes.

Salutaris Medical Devices Inc. (SalutarisMD) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their SMD-Sr90-DA Radionuclide Brachytherapy Source (RBS). The SMD-Sr90-DA RBS device is indicated for episcleral brachytherapy. The device is intended for use within a manual brachytherapy applicator system.
 
Dr. Laurence Marsteller, CEO of SalutarisMD, commented, “The SalutarisMD team is quite proud and excited to have reached this important regulatory and commercial milestone. It further validates our company’s progress, and advances its clinical research agenda.”
 
SalutarisMD is developing a minimally invasive procedure that can be performed in an outpatient setting in approximately 15 minutes. The patented and patent pending technology delivers a single-use brachytherapy procedure. SalutarisMD’s technology is being engineered to deliver improved outcomes for wet AMD.
 
*Caution: Investigational Device

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters